Daratumumab in Primary Antiphospholipid Syndrome

ClinicalTrials.gov ID: NCT05671757

Public ClinicalTrials.gov record NCT05671757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Targeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI)

Study identification

NCT ID: NCT05671757
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Enrollment: 22 participants

Conditions and interventions

Conditions

Autoimmune Disorders

Interventions

Daratumumab Biological

Biological

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 25, 2023
Primary completion: Jun 23, 2026
Completion: Feb 28, 2027
Last update posted: Apr 1, 2026

2023 – 2027

United States locations

U.S. sites: 8
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
Johns Hopkins University	Baltimore	Maryland	21205	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Completed
Northwell Health	Great Neck	New York	11021	Recruiting
NYU Langone	New York	New York	10016	Recruiting
Hospital for Special Surgery	New York	New York	10021	Recruiting
Weill Cornell	New York	New York	10021	Recruiting
Duke University	Durham	North Carolina	27710	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05671757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 1, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05671757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →